至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Intra-amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses

Cell Prolif. 2022; 
Xiaowei Wei, Wei Ma, Hui Gu, Dan Liu, Wenting Luo, Songying Cao, Shanshan Jia, Tianchu Huang, Yiwen He, Yuzuo Bai, Weilin Wang, Zhengwei Yuan
Products/Services Used Details Operation
Gene Synthesis … Primers for the PCR were purchased from GenScript Biotech Corporation (Nanjing, China), with detailed primer information provided in Table 1. The PCR was performed on the ABI … Get A Quote

摘要

objective: Spina bifida aperta (SBA) is one of the most common neural tube defects. Neural injury in SBA occurs in two stages involving failed neural tube closure and progressive degeneration through contact with the amniotic fluid. We previously suggested that intra-amniotic bone marrow-derived mesenchymal stem cell (BMSC) therapy for fetal rat SBA could achieve beneficial functional recovery through lesion-specific differentiation. The aim of this study is to examine whether the amniotic fluid microenvironment can be improved by intra-amniotic BMSC transplantation. methods: The intra-amniotic BMSC injection was performed using in vivo rat fetal SBA models. The various cytokine expressions in rat amniotic flui... More

关键词